Award

Identifying predictors of endocrine therapy toxicity and effective management strategies to improve quality of life for patients with breast cancer

Description: Anti-hormone therapy helps lower the chance that breast cancer will return. However, up to half of patients stop taking it early because the side effects are hard to live with. During this grant, we have focused on side effects from a type of anti-hormone medicine called aromatase inhibitors. These medicines can cause joint aches, pain, and stiffness, which is called AIMSS. Doctors and scientists still do not know exactly why some people get these symptoms. There are few good treatments for AIMSS. Acupuncture helps some patients, but it is expensive and many patients do not use it. We therefore tested acupressure, which is similar to acupuncture but uses finger pressure instead of needles, to see if it can reduce AIMSS symptoms. Unfortunately, in our study acupressure did not work better the fake ("sham") version, and only about half of patients had a meaningful improvement in their pain. We still need more ways to treat these side effects, so more patients with breast cancer can stay on their medicine. In this grant, we are testing two new ways to try to help patients tolerate aromatase inhibitor medication better. First, we found that people with more "healthy" gut bacteria, which have been associated with less inflammation in the body, seemed more likely to be able to keep taking their aromatase inhibitor and less likely to stop because of joint pain. To further investigate this finding, we are running a clinical study of 20 patients who are starting treatment with an aromatase inhibitor. Each person will take a fiber-like supplement called resistant starch for 6 months while also taking the aromatase inhibitor. We will track both the levels of “healthy” bacteria in their stool and their symptoms over time to see if taking this prebiotic will help patients tolerate the aromatase inhibitor medication better. Next, studies have shown that the new weight loss medications called GLP-1 agonists may reduce inflammation in the body in addition to helping patients lose weight. We are therefore planning to test whether treating patients who have AIMSS symptoms with a low dose of this medication may help lower their joint pain and stiffness from the aromatase inhibitor medication. We continue to strive to increase our understanding of why some patients develop side effects from treatment. This knowledge will help us identify ways to reduce side effects, so patients can keep taking their anti-cancer therapy while maintaining their quality of life.
Amount: $450,000
Funding type: award
Start date: 2026-10-01
End date: 2028-09-30
Investigator: Norah Henry (lead)
Institutions: University of Michigan, The Regents of the University of Michigan
Subfield: Oncology
Field: Medicine
Funded outputs count: 0
Funder award ID: BCRF-26-206
OpenAlex ID: G9000360608